These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2502631)

  • 1. On the structure selectivity problem in drug design. A comparative study of benzylpyrimidine inhibition of vertebrate and bacterial dihydrofolate reductase via molecular graphics and quantitative structure-activity relationships.
    Selassie CD; Fang ZX; Li RL; Hansch C; Debnath G; Klein TE; Langridge R; Kaufman BT
    J Med Chem; 1989 Aug; 32(8):1895-905. PubMed ID: 2502631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the inhibition of Escherichia coli and Lactobacillus casei dihydrofolate reductase by 2,4-diamino-5-(substituted-benzyl)pyrimidines: quantitative structure-activity relationships, X-ray crystallography, and computer graphics in structure-activity analysis.
    Hansch C; Li R; Blaney JM; Langridge R
    J Med Chem; 1982 Jul; 25(7):777-84. PubMed ID: 6809941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of chicken liver dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines. A quantitative structure-activity relationship and graphics analysis.
    Selassie CD; Fang ZX; Li RL; Hansch C; Klein T; Langridge R; Kaufman BT
    J Med Chem; 1986 May; 29(5):621-6. PubMed ID: 3701780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the optimization of hydrophobic and hydrophilic substituent interactions of 2,4-diamino-5-(substituted-benzyl)pyrimidines with dihydrofolate reductase.
    Selassie CD; Li RL; Poe M; Hansch C
    J Med Chem; 1991 Jan; 34(1):46-54. PubMed ID: 1899453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrofolate reductase inhibition. A study in the use of X-ray crystallography, molecular graphics, and quantitative structure-activity relations in drug design.
    Hansch C
    Drug Intell Clin Pharm; 1982 May; 16(5):391-6. PubMed ID: 6806055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity relationships of 2, 4-diamino-5-(2-X-benzyl)pyrimidines versus bacterial and avian dihydrofolate reductase.
    Selassie CD; Gan WX; Kallander LS; Klein TE
    J Med Chem; 1998 Oct; 41(22):4261-72. PubMed ID: 9784101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallography, quantitative structure-activity relationships, and molecular graphics in a comparative analysis of the inhibition of dihydrofolate reductase from chicken liver and Lactobacillus casei by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(substituted-phenyl)-s-triazine s.
    Hansch C; Hathaway BA; Guo ZR; Selassie CD; Dietrich SW; Blaney JM; Langridge R; Volz KW; Kaufman BT
    J Med Chem; 1984 Feb; 27(2):129-43. PubMed ID: 6420569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the inhibitory action of 5-(substituted-benzyl)-2,4-diaminopyrimidines on dihydrofolate reductase from chicken liver with that from bovine liver.
    Li R; Hansch C; Kaufman BT
    J Med Chem; 1982 Apr; 25(4):435-40. PubMed ID: 7069722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Dietrich SW; Blaney JM; Reynolds MA; Jow PY; Hansch C
    J Med Chem; 1980 Nov; 23(11):1205-12. PubMed ID: 7005446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative structure-selectivity relationships. Comparison of the inhibition of Escherichia coli and bovine liver dihydrofolate reductase by 5-(substituted-benzyl)-2,4-diaminopyrimidines.
    Li RL; Dietrich SW; Hansch C
    J Med Chem; 1981 May; 24(5):538-44. PubMed ID: 7017146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationship of antifolate inhibition of bacteria cell cultures resistant and sensitive to methotrexate.
    Coats EA; Genther CS; Selassie CD; Strong CD; Hansch C
    J Med Chem; 1985 Dec; 28(12):1910-6. PubMed ID: 3934385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative structure-activity relationships for the inhibition of Escherichia coli dihydrofolate reductase by 5-(substituted benzyl)-2,4-diaminopyrimidines.
    Li RL; Poe M
    J Med Chem; 1988 Feb; 31(2):366-70. PubMed ID: 3276891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure-activity relationships of antimalarial and dihydrofolate reductase inhibition by quinazolines and 5-substituted benzyl-2,4-diaminopyrimidines.
    Hansch C; Fukunaga JY; Jow PY
    J Med Chem; 1977 Jan; 20(1):96-102. PubMed ID: 319234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative structure-activity relationship of 5-(X-benzyl)-2,4-diaminopyrimidines inhibiting bovine liver dihydrofolate reductase.
    Blaney JM; Dietrich SW; Reynolds MA; Hansch C
    J Med Chem; 1979 Jun; 22(6):614-7. PubMed ID: 458817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on the synthesis of dihydrofolate reductase inhibitor, 5-(substituted phenyl)-thio(seleno)-2, 4-diaminopyrimidines and their inhibitory activity on L. casei and chicken liver DHFR].
    Zhang WS; Li RL; Wang QJ
    Yao Xue Xue Bao; 1987 Feb; 22(2):136-40. PubMed ID: 3113176
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure selectivity problem in drug design with respect to antifolates.
    Dias Selassie C; Li RL; Hansch CH; Klein T; Langridge R; Kaufman BT; Freisheim J; Khwaja T
    Prog Clin Biol Res; 1989; 291():341-4. PubMed ID: 2498904
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of Pneumocystis carinii, Toxoplasma gondii, and Mycobacterium avium dihydrofolate reductases by 2,4-diamino-5-[2-methoxy-5-(omega-carboxyalkyloxy)benzyl]pyrimidines: marked improvement in potency relative to trimethoprim and species selectivity relative to piritrexim.
    Rosowsky A; Forsch RA; Queener SF
    J Med Chem; 2002 Jan; 45(1):233-41. PubMed ID: 11754594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of Leishmania dihydrofolate reductase and Leishmania growth by 5-benzyl-2,4-diaminopyrimidines.
    Sirawaraporn W; Sertsrivanich R; Booth RG; Hansch C; Neal RA; Santi DV
    Mol Biochem Parasitol; 1988 Oct; 31(1):79-85. PubMed ID: 3185614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the inhibition of methotrexate-sensitive and -resistant Lactobacillus casei cell cultures with purified Lactobacillus casei dihydrofolate reductase by 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-(3-substituted-phenyl)-s-triazines. Use of quantitative structure-activity relationships in making inferences about the mechanism of resistance and the structure of the enzyme is situ compared with the enzyme in vitro.
    Coats EA; Genther CS; Dietrich SW; Guo ZR; Hansch C
    J Med Chem; 1981 Dec; 24(12):1422-9. PubMed ID: 6796688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dihydrofolate reductase: structure-activity correlations of 2,4-diamino-5-benzylpyrimidines based upon molecular shape analysis.
    Hopfinger AJ
    J Med Chem; 1981 Jul; 24(7):818-22. PubMed ID: 7277386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.